NCT00376077 - A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions

Immune Thrombocytopenic Purpura

Interventions

DRUG

Methylprednisolone and IVIG

Combination therapy (IV MP (Solu-Medrol®, Upjohn) 30 mg/kg (max. 1 g) over 1 hour followed by IVIG 1 g/kg (Gamunex Immune Globulin Intravenous \[Human\], 10%; Bayer)\* x 1 dose

DRUG

Placebo and IVIG

Placebo followed by IVIG 1 g/kg (Gamunex Immune Globulin Intravenous \[Human\], 10%; Bayer)\* x 1 dose

Trial Locations (1)

M5G 1X8

Hospital for Sick Children, Toronto